Diabetes mellitus, fasting glucose, and risk of cause-specific death
Individuals using GLP-1 medications are also advised to limit high-fat and sugary foods and to prioritize adequate hydration to avoid common side effects
In the study conducted by Jiang et al., it was found that serum levels of IGFBP-3 were significantly lower in CRC patients compared to healthy controls
Scientists are continuing to study these medications, and much is still unknown about their role in healthy aging for people without approved medical indications
[DOI] [PMC free article] [PubMed] [Google Scholar] 144.Zhang J., Xiang H., Liu J., Chen Y., He R.R., Liu B
It is plausible, based on pathophysiological understanding, that combining optimized respiratory therapy with the metabolic benefits of BMS delivers additive cardiovascular risk reduction, a hypothesis that warrants testing in standardized clinical trials